Home
>
National Drug Code (NDC)
>
L-Cysteine Hydrochloride
L-Cysteine Hydrochloride - 0517-2050-05 - (L-Cysteine Hydrochloride)
Drug Information of L-Cysteine Hydrochloride
| Product NDC: | 0517-2050 |
| Proprietary Name: | L-Cysteine Hydrochloride |
| Non Proprietary Name: | L-Cysteine Hydrochloride |
| Active Ingredient(s): | 50 mg/mL & nbsp; L-Cysteine Hydrochloride |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of L-Cysteine Hydrochloride
| Product NDC: | 0517-2050 |
| Labeler Name: | American Regent, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 20000101 |
Package Information of L-Cysteine Hydrochloride
| Package NDC: | 0517-2050-05 |
| Package Description: | 5 VIAL, DISPENSING in 1 TRAY (0517-2050-05) > 50 mL in 1 VIAL, DISPENSING |
NDC Information of L-Cysteine Hydrochloride
| NDC Code | 0517-2050-05 |
| Proprietary Name | L-Cysteine Hydrochloride |
| Package Description | 5 VIAL, DISPENSING in 1 TRAY (0517-2050-05) > 50 mL in 1 VIAL, DISPENSING |
| Product NDC | 0517-2050 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | L-Cysteine Hydrochloride |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20000101 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | American Regent, Inc. |
| Substance Name | CYSTEINE HYDROCHLORIDE |
| Strength Number | 50 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |
